Roy A. Whitfield, Director of Nektar Therapeutics NKTR, has filed 0 purchases and 1 sale on the open market. The latest trade was on 09/23.

RW

RW

Roy A. Whitfield

Director

Company

Nektar Therapeutics NKTR

First filing

23/06/15

Trades

5 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

09/23

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Nektar TherapeuticsNKTR	Open-market sale10b5-1 plan	23/06/14	23/06/15	30,000 sh	$0.57	$17,100	−12.2%